The Morning Hype: Intel to Buy Mobileye, Pharma is Scared of Deregulation, and Another Blizzard for NYC

The Morning Hype: Intel to Buy Mobileye, Pharma is Scared of Deregulation, and Another Blizzard for NYC

Research  these Stocks on Kapitall’s Playground Now

 
research now

 

REPORT: Intel to Aquire Mobileye for $15BN (via Bloomberg)

Oil Prices Are Very Low, Amercain Supply is High (via Reuters)

Musk Wants to Help Australia with Their Energy Problems (via MarketWatch)

The is A Mumps Outbreak Hitting Across the U.S (via Gizmodo)

Trump's Deregulation is Making Pharma Companies Nervous (via Fortune)

Taxpayers Are Still Slow to File (via Forbes)

Bugatti is Now Making Yachts (via The Verge)

A Republican Bill is Moving to Let Your Employer Genetically Test You (via Mashable)

Scotland Gets Another Referendum (via Business Insider)

NYC: Be Prepared, Another Blizzard is On the Way (via Gothamist)

 

ABOUT US

© New Kapitall Holdings LLC. All rights reserved. Kapitall Wire is a division of New Kapitall Holdings LLC. Kapitall Generation, LLC is a wholly owned subsidiary of New Kapitall Holdings LLC.

Kapitall Wire offers free cutting edge investing ideas, intended for educational information purposes only. It should not be construed as an offer to buy or sell securities, or any other product or service provided by New Kapitall Holdings, and its affiliate companies.

Open a free account today get access to virtual cash portfolios, cutting-edge tools, stock market insights, and a live brokerage platform through our affiliated company, Kapitall Generation, LLC. 

Securities products and services are offered by Kapitall Generation, LLC – a FINRA/SIPC member. For more information, see full disclosures and fees. 

stockstarsbanners640x1362jpg

One response to “The Morning Hype: Intel to Buy Mobileye, Pharma is Scared of Deregulation, and Another Blizzard for NYC”

Leave a Reply

Your email address will not be published. Required fields are marked *

wirebanner1jpg
  • See Most Recent Articles